Woodline Partners LP - 30 Jun 2025 SCHEDULE 13G/A Report for Aligos Therapeutics, Inc. Voting Common Stock, par value $0.0001 per share (ALGS)

Filing Manager: Woodline Partners LP
Reporting Manager: Woodline Partners LP
Security: Aligos Therapeutics, Inc. Voting Common Stock, par value $0.0001 per share
Symbol: ALGS
Shares outstanding: 5,288,776 shares
Disclosed Ownership: 518,300 shares
Ownership: 9.8%
Form type: SCHEDULE 13G/A
Filing time: 14 Aug 2025, 11:54:19 UTC
Date of event: 30 Jun 2025
Previous filing: 15 May 2025
Next filing: 14 Nov 2025
SEC: View on sec.gov

Reporting Managers (1)

Name	Ownership	Shares Owned	sole voting power	shared voting power	Signature	Title	CIK
Woodline Partners LP	9.8%	518,300	518,300	0	/s/ Erin Mullen	Erin Mullen, General Counsel & Chief Compliance Officer